Health & Life Sciences

Our lawyers have advised a range of clients on various Health, Food & Life Sciences matters, including:

  • Collaboration Agreements
  • Shareholder Agreements
  • Mergers, Roll-up, Aggregation & Acquisition transactions
  • Buy-ins, joint ventures, and various other commercial transactions
  • Term Sheets, MOUs, HOAs
  • Licence Agreements
  • Intellectual Property Commercialisation
  • Partnership Agreements
  • Franchising Arrangements
  • Supply & Distribution Agreements
  • Capital Markets, Fund Raising and IPOs

Members of our team have been ranked: in the Australasian Legal Business Mergers & Acquisitions Guide as Leading Lawyer, in the Asia Pacific Legal 500 in Australia, for ECM in Chambers Global, and in The Legal Media Group Guide to Leading Capital Markets Lawyers.


Our lawyers have advised and acted on a number of Health, Food, Life Sciences, Technology and IP projects, including:

    • Aggregation – currently advising on an aggregation of  medical service providers and proposed initial public offering
    • Q-Scan Radiology Group –  advised on acquisitions, buy-ins, joint ventures, commercial leases, franchise agreements and various other commercial transactions
    • Citi-Scan Group – advised on joint venture and various commercial agreements
    • Life Fertility Clinics – advised on acquisitions, buy-in and corporate matters
    • UV Natural – acted on its manufacturing, joint venture and supply agreements in respect of organic cosmetic/sunscreen products
    • Revive Group – advised on medical services agreements, supply agreement, partner agreements and divestment
    • Bio Concepts – advised on Therapeutic Goods Administration (a regulatory body for therapeutic goods in Australia) compliance issues and supply/distribution
    • APM – advised on major contracts regarding Federal Government’s ‘My Aged Care Regional Assessment Service’
    • NBC/Fenix Fitness – acted on the aggregation of various fitness gym acquisitions. Acted for management on the sale to Goodlife.
    • Private consortia – currently advising a group on the development of an health services exchange platform on capital raising, seed & multi-series issues, dilution and sweat equity matters
    • Acted for a consortium of medical professionals in negotiating a lease for a medical centre
    • Acted in respect of an acquisition of pharmacy target
    • Ajinomoto Pharmaceuticals Europe Ltd – advised on a Clinical Development Master Service Agreement
    • Research & Development agreements – Advised on research and development programs for hardware, software and emerging technologies, commercialisation and protection of IP for IT products and services